Share '[Webinar] FibroGen Update on Pamrevlumab & Currently Enrolling Non-Ambulatory Study'
Please join Parent Project Muscular Dystrophy and FibroGen as we host a webinar Wednesday, October 25 at 1:00 PM EDT to hear a community update on FibroGen’s development of Pamrevlumab and currently enrolling FGCL-3019-079 non-ambulatory study in Duchenne muscular dystrophy.
Kathi Kinnett, MSN, CNP Senior Vice President, Clinical Care Parent Project Muscular Dystrophy…
You can share this event in two ways…
Share this link:
Send it with your computer's email program: Email this